KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Raw Materials (2016 - 2025)

Historic Raw Materials for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $849.0 million.

  • Boston Scientific's Raw Materials rose 366.3% to $849.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $849.0 million, marking a year-over-year increase of 366.3%. This contributed to the annual value of $849.0 million for FY2025, which is 366.3% up from last year.
  • Per Boston Scientific's latest filing, its Raw Materials stood at $849.0 million for Q4 2025, which was up 366.3% from $849.0 million recorded in Q3 2025.
  • Over the past 5 years, Boston Scientific's Raw Materials peaked at $860.0 million during Q3 2024, and registered a low of $366.0 million during Q1 2021.
  • In the last 5 years, Boston Scientific's Raw Materials had a median value of $727.5 million in 2023 and averaged $666.8 million.
  • In the last 5 years, Boston Scientific's Raw Materials plummeted by 2199.17% in 2021 and then skyrocketed by 4108.82% in 2023.
  • Quarter analysis of 5 years shows Boston Scientific's Raw Materials stood at $452.0 million in 2021, then rose by 21.24% to $548.0 million in 2022, then surged by 41.06% to $773.0 million in 2023, then grew by 5.95% to $819.0 million in 2024, then grew by 3.66% to $849.0 million in 2025.
  • Its Raw Materials was $849.0 million in Q4 2025, compared to $849.0 million in Q3 2025 and $835.0 million in Q2 2025.